MEDXFMEDXFOTC
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank49
3Y CAGR-23.8%
5Y CAGR-37.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-23.8%/yr
Quarterly compound
5Y CAGR
-37.9%/yr
Recent acceleration
Percentile
P49
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 21.64% |
| Q3 2025 | 62.00% |
| Q2 2025 | 172.71% |
| Q1 2025 | -130.92% |
| Q4 2024 | 130.97% |
| Q3 2024 | -58.81% |
| Q2 2024 | 377.64% |
| Q1 2024 | -46.94% |
| Q4 2023 | -55.88% |
| Q3 2023 | -26.57% |
| Q2 2023 | 77.03% |
| Q1 2023 | -5.72% |
| Q4 2022 | 48.95% |
| Q3 2022 | 5800.00% |
| Q2 2022 | 101.32% |
| Q1 2022 | -638.64% |
| Q4 2021 | 93.21% |
| Q3 2021 | 30.31% |
| Q2 2021 | -52.65% |
| Q1 2021 | -399.13% |
| Q4 2020 | 234.31% |
| Q3 2020 | -59.95% |
| Q2 2020 | 216.44% |
| Q1 2020 | 60.37% |
| Q4 2019 | -159.90% |
| Q3 2019 | -11.78% |
| Q2 2019 | 45.11% |
| Q1 2019 | -2684.62% |
| Q4 2018 | 97.86% |
| Q3 2018 | -732.88% |
| Q2 2018 | 64.32% |
| Q1 2018 | -57.85% |
| Q4 2017 | -1254.84% |
| Q3 2017 | 93.47% |
| Q2 2017 | 22.97% |
| Q1 2017 | -43.45% |
| Q4 2016 | -32.11% |
| Q3 2016 | 66.26% |
| Q2 2016 | -199.83% |
| Q1 2016 | 266.01% |